Study Comparing TPI-120 and Neulasta Administered Through Subcutaneous Route in Healthy Adult Subjects
Clinical trial NCT03206229 · COMPLETED
Trial details
- NCT number
- NCT03206229
- Sponsor
- Adello Biologics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-13
- Primary completion
- 2017-06-02
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.